Related Experiment Video
Updated: Aug 12, 2026
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
[Stefin A--potential application in oncological laboratory diagnosis]
1Katedra i Zakład Biochemii Farmaceutycznej Akademii Medycznej we Wrocławiu. warwas@bf.uni.wroc.pl
Abstract:
This is a review of studies on stefin A, an intracellular cysteine peptidase inhibitor of cystatin superfamily. Cystatins and target cysteine peptidases, such as cathepsins B and L have been implicated in malignant progression. The biochemical characteristics of human stefin A and its functions are presented. Special attention was paid to the potential usefulness of stefin A determination in serum and tissue cytosol (ELISA test) or tissue sections (immunohistochemistry) in the oncological laboratory diagnosis.
Insights
This review explores stefin A, a cysteine peptidase inhibitor. Stefina A determination may aid in oncological laboratory diagnosis for cancer progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Context:
- Cystatin superfamily inhibitors, including stefin A, play roles in cellular processes.
- Cysteine peptidases like cathepsins B and L are linked to cancer progression.
- Understanding stefin A's function is crucial in cancer research.
Purpose:
- To review the biochemical characteristics and functions of human stefin A.
- To evaluate the diagnostic potential of stefin A in oncological settings.
- To highlight stefin A's role as an intracellular cysteine peptidase inhibitor.
Summary:
- Stefina A is an intracellular cysteine peptidase inhibitor belonging to the cystatin superfamily.
- Its biochemical properties and functions are detailed, with a focus on its role in malignant progression.
- The review examines the utility of stefin A measurement in serum and tissues for cancer diagnosis.
Impact:
- Potential for improved oncological laboratory diagnosis using stefin A.
- Enhanced understanding of stefin A's involvement in cancer pathogenesis.
- Opens avenues for developing stefin A-based biomarkers for cancer detection.
